» Articles » PMID: 22495786

Untreated HIV Infection is Associated with Higher Blood Alcohol Levels

Overview
Date 2012 Apr 13
PMID 22495786
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alcohol abuse has been associated with HIV/AIDS progression, but the effects of HIV infection and treatment on alcohol exposure have not been explored to date. This pilot study examines the relationship of untreated HIV infection to blood alcohol concentrations (BAC) relative to BAC after initiation of antiretroviral therapy (ART).

Methods: Fifteen volunteers with untreated HIV/AIDS participated in 2 sets of alcohol or alcohol placebo administration studies before and after initiation of ART. Oral alcohol (1 g/kg) or alcohol placebo was administered, participants were followed for pharmacokinetics, subjective responses, and cognitive effects over 8 hours. After initial alcohol studies, the ART regimen selected by participant clinicians was instituted. Observed ART dosing took place for at least 2 weeks. Participants then returned for a second set of alcohol/placebo administration studies while on ART.

Results: Participants had significantly higher BAC (P < 0.001) before ART than after ART administration. Alcohol area under the curve was significantly higher in untreated HIV disease (P = 0.011) with significantly higher C(max) (P = 0.015) and C(min) (P = 0.05). The elimination rate was not different between pre-ART and post-ART conditions. Despite declines in BAC after ART initiation, no differences in subjective responses were observed with alcohol administration.

Conclusions: Untreated HIV infection is associated with risk for higher BAC than that observed after ART. These findings indicate that patients with untreated HIV disease who ingest alcohol are at greater risk for alcohol associated adverse events and toxicities and underscores the need for simultaneous treatment of alcohol use disorders and HIV in patients with co-occurring conditions.

Citing Articles

Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV.

McGinnis K, Tate J, Bryant K, Justice A, OConnor P, Rodriguez-Barradas M AIDS Behav. 2021; 26(3):786-794.

PMID: 34542779 DOI: 10.1007/s10461-021-03438-y.


Sociodemographic and clinical factors associated with transdermal alcohol concentration from the SCRAM biosensor among persons living with and without HIV.

Richards V, Liu Y, Orr J, Leeman R, Barnett N, Bryant K Alcohol Clin Exp Res. 2021; 45(9):1804-1811.

PMID: 34342009 PMC: 8526382. DOI: 10.1111/acer.14665.


Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Giacometti L, Barker J Brain Res. 2019; 1723:146390.

PMID: 31421128 PMC: 6766419. DOI: 10.1016/j.brainres.2019.146390.


Lower Blood Alcohol Concentration Among HIV-Positive Versus HIV-Negative Individuals Following Controlled Alcohol Administration.

Shuper P, Joharchi N, Rehm J Alcohol Clin Exp Res. 2018; 42(9):1684-1692.

PMID: 29928776 PMC: 6120761. DOI: 10.1111/acer.13816.


Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV.

Bilal U, McCaul M, Crane H, Mathews W, Mayer K, Geng E Alcohol Clin Exp Res. 2017; 42(3):561-570.

PMID: 29265385 PMC: 5832592. DOI: 10.1111/acer.13583.


References
1.
Bode C, Bode J . Alcohol's role in gastrointestinal tract disorders. Alcohol Health Res World. 1997; 21(1):76-83. PMC: 6826790. View

2.
Price L, McDougle C, Kosten T, Black J, Jatlow P . Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 1993; 111(1):39-46. DOI: 10.1007/BF02257405. View

3.
Sulkowski M, Moore R, Mehta S, Chaisson R, Thomas D . Hepatitis C and progression of HIV disease. JAMA. 2002; 288(2):199-206. DOI: 10.1001/jama.288.2.199. View

4.
Ancuta P, Kamat A, Kunstman K, Kim E, Autissier P, Wurcel A . Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One. 2008; 3(6):e2516. PMC: 2424175. DOI: 10.1371/journal.pone.0002516. View

5.
Kumar G, Rodrigues A, Buko A, Denissen J . Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. J Pharmacol Exp Ther. 1996; 277(1):423-31. View